APT(SH:688617) Xin Lang Cai Jing·2025-11-05 03:51Group 1 - The core viewpoint of the news is that Shenzhen Huatai Medical has seen a stock price increase of 5.11%, reaching 289.48 CNY per share, with a total market capitalization of 40.821 billion CNY [1] - Shenzhen Huatai Medical specializes in the research, production, and sales of electrophysiology and vascular interventional medical devices, with its main business revenue composition being: coronary access 53.90%, electrophysiology 20.23%, peripheral intervention 17.51%, OEM 6.01%, non-vascular intervention 1.88%, and others 0.46% [1] Group 2 - According to data from the top ten holdings of funds, one fund under Jianxin Fund has a significant position in Huatai Medical, specifically the Jianxin CSI All-Share Medical Equipment and Services ETF (159891), which reduced its holdings by 400 shares in the third quarter, now holding 12,400 shares, accounting for 2.88% of the fund's net value [2] - The Jianxin CSI All-Share Medical Equipment and Services ETF (159891) has a current scale of 137 million CNY, with a year-to-date return of 6.28%, ranking 3906 out of 4216 in its category, and a one-year return of 1.71%, ranking 3744 out of 3901 [2] Group 3 - The fund manager of Jianxin CSI All-Share Medical Equipment and Services ETF (159891) is Gong Jiajia, who has been in the position for 6 years and 259 days, with the fund's total asset size at 1.056 billion CNY [3] - During Gong Jiajia's tenure, the best fund return was 44.21%, while the worst return was -53.64% [3]